Home › Research › Topics › complications
complications
7 studies tagged complications, dated 1991-07-01 to 2025-10-11. Bibliography: BibTeX (.bib) · RIS (.ris)
Newest in this topic
- Ocular Complications of SGLT-2 Inhibitors, GLP-1 Receptor Agonists, and DPP-4 Inhibitors in T2DM Treatments: A Retrospective Real-World Cohort Study 2025-10-11
- The growing range of complications of diabetes mellitus 2025-01-03
- A systematic review of neurological symptoms and complications of COVID-19 2020-07-20
Studies
7 studies carry this tag.
Date range
1991 to 2025
Top journals
- Clinical pharmacology and therapeutics 1
- Journal of hepatology 1
- Journal of neurology 1
- Journal of the American Geriatrics Society 1
- Mini reviews in medicinal chemistry 1
7 journals in all.
Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.
-
Glaucoma is a leading cause of irreversible vision loss worldwide, and type 2 diabetes mellitus (T2DM) is increasingly recognized as a risk factor for glaucoma.
-
With the rising prevalence of type 2 diabetes mellitus (T2DM) and obesity, several previously under-recognised complications associated with T2DM are becoming more evident.
-
The most frequent neurological symptoms reported in association with COVID-19 are non-specific for the infection with SARS-CoV-2.
-
Median follow-up was 5.7 years (range, 2 to 14.4 years).
-
36/100
Type 2 diabetes is a major health problem associated with excess mortality and morbidity.
-
Hepatic encephalopathy (HE) is a major neuropsychiatric complication of cirrhosis.
-
A variety of neuropharmacologic agents, including anticholinergic drugs, amantadine hydrochloride, levodopa, selegiline, bromocriptine, and pergolide, are now available for the treatment of Parkinson's disease.